Emergence of community behaviors in the gut microbiota upon drug treatment
Cell,
Journal Year:
2024,
Volume and Issue:
187(22), P. 6346 - 6357.e20
Published: Sept. 24, 2024
Pharmaceuticals
can
directly
inhibit
the
growth
of
gut
bacteria,
but
degree
to
which
such
interactions
manifest
in
complex
community
settings
is
an
open
question.
Here,
we
compared
effects
30
drugs
on
a
32-species
synthetic
with
their
each
member
isolation.
While
most
individual
drug-species
remained
same
context,
communal
behaviors
emerged
26%
all
tested
cases.
Cross-protection
during
drug-sensitive
species
were
protected
was
6
times
more
frequent
than
cross-sensitization,
converse
phenomenon.
decreased
and
cross-sensitization
increased
at
higher
drug
concentrations,
suggesting
that
resilience
microbial
communities
collapse
when
perturbations
get
stronger.
By
metabolically
profiling
drug-treated
communities,
showed
both
biotransformation
bioaccumulation
contribute
mechanistically
protection.
As
proof
principle,
molecularly
dissected
prominent
case:
expressing
specific
nitroreductases
degraded
niclosamide,
thereby
protecting
themselves
sensitive
members.
Language: Английский
Emergence of community behaviors in the gut microbiota upon drug treatment
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: June 14, 2023
Summary
Pharmaceuticals
can
directly
inhibit
the
growth
of
gut
bacteria,
but
degree
such
interactions
manifest
in
complex
community
settings
is
an
open
question.
Here
we
compared
effects
30
drugs
on
a
32-species
synthetic
with
their
each
member
isolation.
While
most
individual
drug–species
remained
same
context,
communal
behaviors
emerged
26%
all
tested
cases.
Cross-protection,
during
which
drug-sensitive
species
became
protected
community,
was
6-times
more
frequent
than
cross-sensitization,
converse
phenomenon.
Cross-protection
decreased
and
cross-sensitization
increased
at
higher
drug
concentrations,
suggesting
that
resilience
microbial
communities
collapse
when
perturbations
get
stronger.
By
metabolically
profiling
drug-treated
communities,
showed
both
biotransformation
bioaccumulation
contribute
mechanistically
to
protection.
As
proof-of-principle,
molecularly
dissected
prominent
case:
expressing
specific
nitroreductases
degraded
niclosamide,
thereby
protecting
themselves
sensitive
members.
Language: Английский